Skip to main content

Month: June 2025

Broadcom Announces New CloudHealth User Experience for Greater Cloud Spend Management Across Enterprise Teams

New AI-powered Features Deliver Actionable Insights and Enhanced Collaboration PALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) — Broadcom (NASDAQ: AVGO) today announced the general availability of the newest investment made to VMware Tanzu CloudHealth, a comprehensive new user experience that delivers a suite of feature enhancements and new AI-powered features like Intelligent Assist and Smart Summary. The new CloudHealth experience brings more accurate data and actionable insights to the entire FinOps Team, making it easier to achieve critical FinOps-driven outcomes and better align investments with business goals. Designed to reduce barriers to entry by making FinOps tools and capabilities available to personas of all backgrounds, it allows all stakeholders in the FinOps practice to better understand their impact and input...

Continue reading

Foremost Clean Energy Strengthens Leadership Team with Appointment of Cameron MacKay as Vice President of Exploration

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased to announce the appointment of Cameron MacKay as Vice President of Exploration effective June 01, 2025. Mr. MacKay is a seasoned uranium exploration executive with over a decade of experience and a track record of uranium discovery in the Athabasca Basin. “We are extremely pleased to welcome Cameron to Foremost’s leadership team,” said Jason Barnard, President and CEO of Foremost Clean Energy. “Cameron’s proven ability to identify and test high-potential exploration targets will be invaluable as we execute on our ambitious strategy to actively explore our unique portfolio of 10 uranium exploration properties in the Athabasca Basin. Cameron’s deep...

Continue reading

ASUS Wins 41 Prestigious Red Dot Design Awards for Product Design 2025, Showcasing World-Class Excellence

International recognition of cutting-edge ASUS design, innovation, and craftsmanship across five diverse product categoriesTORONTO, June 02, 2025 (GLOBE NEWSWIRE) — ASUS today announced that it has been honored with 41 Red Dot Design Awards for Product Design 2025, reinforcing the company’s long-standing reputation for pushing the boundaries of innovation and excellence in product design. These wins highlight the ASUS commitment to creating technology that excels in both form and function, in line with its In Search of Incredible spirit. The awards were earned across a wide range of Product Design categories: Computer and Information Technology (35 awards), Mobile Phones, Tablets and Wearables (3), Luggage and Bag (1), TV and Home Entertainment (1), and Communication Technology (1). Each product recognized demonstrates...

Continue reading

Cemtrex’s Vicon Expands Leadership in UK Prison Security Market with New Wave of System Orders

Hauppauge, NY, June 02, 2025 (GLOBE NEWSWIRE) —   Vicon Industries, a subsidiary of Cemtrex Inc. (Nasdaq: CETX) and a leading provider of advanced security and surveillance solutions, today announced it has secured a new set of significant orders from correctional facilities in the United Kingdom. The contracts, valued at approximately $.8 million, further Vicon’s position as a trusted provider in one of the world’s most regulated and demanding surveillance environments. The orders came through a long-term integration partner of Vicon and include advanced surveillance hardware and software for multiple prisons and an immigration center. Each deployment features a tailored mix of Vicon’s advanced outdoor dome and bullet cameras, Valerus enterprise video management licenses, and high-performance recording servers, all optimized for...

Continue reading

Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types

MONSTAR-SCREEN-3 study showed 100% detection of circulating tumor DNA (ctDNA) at baseline timepoint, and 60% of patients testing positive one month after surgery had tumor fractions only detectable via ultra-sensitive MRD SALT LAKE CITY, June 02, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced new molecular residual disease (MRD) clinical data from the MONSTAR-SCREEN 3 study, a collaboration with the National Cancer Center Hospital East (NCCHE) in Japan, demonstrating successful pan-cancer implementation of Myriad’s ultra-sensitive Precise™ MRD Test to detect and monitor ctDNA in patients. The interim results – first shared at the 2025 ASCO Annual Meeting by Tadayoshi Hashimoto, MD, PhD of the NCCHE – achieved 100% baseline detection...

Continue reading

AmpliTech Group To Participate In The “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Virtual Conference Presented By Maxim Group LLC

HAUPPAUGE, N.Y., June 02, 2025 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer, developer, and manufacturer of advanced signal processing components for satellite, public and private 5G, and other communications networks, including full 5G/6G system design and global distribution of integrated circuit assembly packages and lids, announced today that AmpliTech’s Group CEO/CTO Fawad Maqbool has been invited to present at the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” presented by Maxim Group LLC, on Tuesday, June 3rd – Thursday, June 5th at 9:00 a.m. EDT The rapid evolution of technology is paving the way for disruption across all industries, including healthcare, drones, consumer IoT, business solutions, gaming & entertainment, and more. In Maxims 2025 Virtual...

Continue reading

New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression

SOLANA BEACH, Calif., June 02, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological or neurological conditions, today welcomed the publication of a comprehensive review in Neurobiology of Disease, titled “Fatty acid binding proteins and their involvement in anxiety and mood disorders,” that underscores the therapeutic potential of Fatty Acid Binding Protein (FABP) inhibitors in treating mood and anxiety disorders. The peer-reviewed article was co-authored by Doctor Steven Laviolette, Professor in the Schulich School of Medicine along with other researchers from the University of Western Ontario, Canada, details extensive preclinical evidence supporting FABP5,...

Continue reading

Actuate Therapeutics Shares Highlights from KOL Event on Positive Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer

– Expert Insights on Clinical Relevance and Scientific Rationale– The replay of the event is available on the Investor Relations section of the Actuate website CHICAGO and FORT WORTH, Texas, June 02, 2025 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), today announced key takeaways from its Key Opinion Leader (KOL) event held on May 31, 2025 discussing the positive topline results from the Phase 2 (Actuate-1801 Part 3B) trial of elraglusib in combination with gemcitabine/nab-paclitaxel (GnP) in previously untreated patients with metastatic pancreatic ductal adenocarcinoma (mPDAC). The...

Continue reading

TerrAscend Announces Chief Financial Officer Transition Plan

TORONTO, June 02, 2025 (GLOBE NEWSWIRE) — TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced that Keith Stauffer, Chief Financial Officer, will be departing the Company on July 18, 2025, to pursue a career opportunity outside of the cannabis industry. Mr. Stauffer will remain in his role through the transition period to ensure a smooth handover. Effective upon his departure, Alisa Campbell, currently Senior Vice President, Corporate Finance & Accounting, will assume leadership of the Company’s accounting and finance function on an interim basis, reporting to Ziad Ghanem, President and Chief Executive Officer. A comprehensive search for a permanent CFO is underway. Ms. Campbell, who joined TerrAscend in 2020, brings over 20 years of financial...

Continue reading

DeFi Dev Corp. Becomes First Public Company With an LST to Be Integrated Into Kamino, Solana’s Premier DeFi Lending Protocol

BOCA RATON, FL, June 02, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced an LOI with Kamino Finance, the largest Solana DeFi lending protocol with more than $4B in deposited assets. As part of the collaboration, Kamino intends to integrate dfdvSOL, an LST built by Sanctum, into its suite of capital-efficient DeFi products. The partnership will see dfdvSOL added to Kamino’s borrow/lend markets, allowing users to supply or borrow against dfdvSOL as collateral, as well as included in Kamino’s Multiply Vaults, which provide users with access to automated leveraged-yield strategies. These integrations will be designed to enhance the utility and yield potential of dfdvSOL...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.